Jason Cohen

About the Author Jason Cohen

Jason is a Smarter Analyst editor and writer, who specializes in biotech and cannabis-based pharmaceutical companies.

Cannabis Strategies Acquisition (CBAQF) Stock at $26? Northland Thinks It’s Possible

There’s little doubt that the burgeoning pot industry offers plenty of opportunity for investors. According to a report by BDS Analytics, global consumer cannabis …

Spark Therapeutics (ONCE): Did You Feel the Ground Shake, Too?

It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …

Teva Stock Slips on Back of Weak 2019 Outlook; Analysts Weigh In

You know there was some bad news with a company’s quarterly update when the stock tanks after the results are announced. That’s what …

Don’t Say Bye Bye to Intercept (ICPT) Stock, Say Buy Buy

With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …

MacroGenics (MGNX) Stock Fires on All Cylinders; Analysts Weigh In

It’s a very rewarding trading day for investors in MacroGenics (MGNX) with shares up over 120%, making the stock Wall Street’s bull of …

Trevena (TRVN) Stock Roars Back to Life; Analysts Dive In

Shares of Trevena (TRVN) came back to life. The struggling biotech stock took a rare leap upward last week, as well as today, as resolution …

Evolus (EOLS) Stock Just Got a Major Face-Lift; Mizuho Analyst Weighs In

Congrats. Evolus (EOLS) is the first company to win FDA approval for a neurotoxin that is considered biosimilar to branded Botox for the …

Teva Stock Gets a Thumbs Up from Merrill Lynch Ahead of Earnings

The turnaround at Teva Pharmaceutical Industries (TEVA) remains on schedule. Investors appear satisfied that CEO Kare Schultz is making enough progress in battling …

Why BioLineRx (BLRX) Stock Spiked Today

A journey of a thousand miles begins with a single step, and a big one in this case. BioLineRx (BLRX) announced this morning that …

Aphria (APHA): Analyst Shares Two Cents on Green Growth Formal Offer

With cannabis legitimized, a number of clearly defined trends have emerged. For instance, dealmaking has been on the rise and acquisitions have picked up.